199 related articles for article (PubMed ID: 32018148)
1. A practical predictor of the growth potential of benign meningiomas: Hypointensity of surface layer in T2-weighted magnetic resonance imaging.
Deguchi S; Nakashima K; Nakasu Y; Mitsuya K; Hayashi N; Ito I; Endo M; Kitahara S; Nakasu S
Clin Imaging; 2020 Jun; 62():10-16. PubMed ID: 32018148
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
3. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
4. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
Abramovich CM; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
[TBL] [Abstract][Full Text] [Related]
5. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
6. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
7. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
[TBL] [Abstract][Full Text] [Related]
8. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
9. The Predictive Value of Conventional Magnetic Resonance Imaging Sequences on Operative Findings and Histopathology of Intracranial Meningiomas: A Prospective Study.
Karthigeyan M; Dhandapani S; Salunke P; Singh P; Radotra BD; Gupta SK
Neurol India; 2019; 67(6):1439-1445. PubMed ID: 31857531
[TBL] [Abstract][Full Text] [Related]
10. Meningioma: proliferating potential and clinicoradiological features.
Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
[TBL] [Abstract][Full Text] [Related]
12. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
13. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
14. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
[TBL] [Abstract][Full Text] [Related]
15. Association of apparent diffusion coefficient with Ki-67 proliferation index, progesterone-receptor status and various histopathological parameters, and its utility in predicting the high grade in meningiomas.
Bozdağ M; Er A; Ekmekçi S
Acta Radiol; 2021 Mar; 62(3):401-413. PubMed ID: 32397733
[TBL] [Abstract][Full Text] [Related]
16. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas.
Ildan F; Tuna M; Göçer AP; Boyar B; Bağdatoğlu H; Sen O; Haciyakupoģlu S; Burgut HR
J Neurosurg; 1999 Sep; 91(3):384-90. PubMed ID: 10470811
[TBL] [Abstract][Full Text] [Related]
18. Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping.
Zhang S; Chiang GC; Knapp JM; Zecca CM; He D; Ramakrishna R; Magge RS; Pisapia DJ; Fine HA; Tsiouris AJ; Zhao Y; Heier LA; Wang Y; Kovanlikaya I
J Neuroradiol; 2020 Jun; 47(4):272-277. PubMed ID: 31136748
[TBL] [Abstract][Full Text] [Related]
19. [Olfactory groove meningioma: correlation between clinicoradiological features and proliferative index (Mib-1)].
Paiva Neto MA; Tella OI; Herculano MA; Stávale JN; Bonatteli AP
Arq Neuropsiquiatr; 2006 Mar; 64(1):77-82. PubMed ID: 16622558
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas.
Vankalakunti M; Vasishta RK; Das Radotra B; Khosla VK
Neuropathology; 2007 Oct; 27(5):407-12. PubMed ID: 18018472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
